Keywords: AEV, acquired epidermodysplasia verruciformis; APDS, activated PI3Kδ syndrome; EV, epidermodysplasia verruciformis; HPV, human papillomavirusl; PI3K, phosphoinositide 3-kinase; PI3Kδ; epidermodysplasia verruciformis; human papillomavirus; immunodeficiency; rapamycin.